These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 19264587)

  • 21. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term use of zonisamide in refractory childhood-onset epilepsy.
    Kluger G; Zsoter A; Holthausen H
    Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levetiracetam monotherapy in children with epilepsy.
    Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A
    Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zonisamide for refractory juvenile absence epilepsy.
    Velizarova R; Crespel A; Genton P; Serafini A; Gelisse P
    Epilepsy Res; 2014 Sep; 108(7):1263-6. PubMed ID: 24907183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and efficacy of zonisamide in patients with refractory partial-onset epilepsy.
    Wroe SJ; Yeates AB; Marshall A
    Acta Neurol Scand; 2008 Aug; 118(2):87-93. PubMed ID: 18547272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discontinuation and duration of antiepileptic drug therapy: a retrospective study of factors for specific epileptic syndromes.
    Kudo T; Nishida T; Yagi K
    Epilepsia; 2004; 45 Suppl 8():26-32. PubMed ID: 15610191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.
    Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF
    Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
    Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
    Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of zonisamide in pediatric patients.
    Santos CC; Brotherton T
    Pediatr Neurol; 2005 Jul; 33(1):12-4. PubMed ID: 15876518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zonisamide in the management of epilepsy--Japanese experience.
    Ohtahara S
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S25-33. PubMed ID: 16321507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management and monitoring of patients treated with zonisamide: the OZONE study.
    Dupont S; Biraben A; Lavernhe G; Marquet T; Allaf B
    Epileptic Disord; 2013 Sep; 15(3):278-88. PubMed ID: 23906691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zonisamide as adjunctive therapy for refractory partial seizures.
    Brodie MJ
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S11-6. PubMed ID: 16316744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacology, efficacy, and tolerability of potassium bromide in childhood epilepsy.
    Korinthenberg R; Burkart P; Woelfle C; Moenting JS; Ernst JP
    J Child Neurol; 2007 Apr; 22(4):414-8. PubMed ID: 17621520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of adjunctive zonisamide therapy for refractory partial seizures.
    Baulac M; Leppik IE
    Epilepsy Res; 2007 Jul; 75(2-3):75-83. PubMed ID: 17553670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term outcome of pattern-sensitive epilepsy.
    Brinciotti M; Matricardi M; Cantonetti L; Lauretti G; Pugliatti M
    Epilepsia; 2006; 47 Suppl 5():36-40. PubMed ID: 17239104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term cognitive and mood effects of zonisamide monotherapy in epilepsy patients.
    Park SP; Hwang YH; Lee HW; Suh CK; Kwon SH; Lee BI
    Epilepsy Behav; 2008 Jan; 12(1):102-8. PubMed ID: 17945539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic generalized epilepsy with generalized tonic-clonic seizures (IGE-GTC): a population-based cohort with >20 year follow up for medical and social outcome.
    Camfield P; Camfield C
    Epilepsy Behav; 2010 May; 18(1-2):61-3. PubMed ID: 20471324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Idiopathic epilepsy with generalized tonic-clonic seizures only versus idiopathic epilepsy with phantom absences and generalized tonic-clonic seizures: one or two syndromes?
    Koutroumanidis M; Aggelakis K; Panayiotopoulos CP
    Epilepsia; 2008 Dec; 49(12):2050-62. PubMed ID: 18616555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Zonisamide prophylaxis in refractory pediatric headache.
    Pakalnis A; Kring D
    Headache; 2006 May; 46(5):804-7. PubMed ID: 16643584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term efficiency of vagus nerve stimulation (VNS) in non-surgical refractory epilepsies in adolescents and adults].
    Montavont A; Demarquay G; Ryvlin P; Rabilloud M; Guénot M; Ostrowsky K; Isnard J; Fischer C; Mauguière F
    Rev Neurol (Paris); 2007 Dec; 163(12):1169-77. PubMed ID: 18355464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.